End-of-day quote
Other stock markets
|
||
- USD | - |
|
Feb. 14 | US FDA approves GSK's combo meningococcal vaccine | RE |
Feb. 14 | Pfizer Insider Bought Shares Worth $499,072, According to a Recent SEC Filing | MT |
Business description: Pfizer Inc
- primary care products (52.3%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (25.6%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (19.9%);
- other (2.2%).
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (33.8%).
Sales by Activity: Pfizer Inc
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Global Biopharmaceuticals Business (Biopharma) | 39.42B | 41.91B | 79.56B | 98.99B | 57.19B |
Upjohn | 10.23B | - | - | - | - |
Other business activities | 2.1B | - | 1.73B | 1.34B | 1.31B |
Geographical breakdown of sales: Pfizer Inc
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
United States | 23.85B | 21.71B | 29.75B | 42.47B | 27.09B |
Emerging Markets | 12.73B | 8.37B | 20.7B | 20.1B | 12B |
Developed Europe | 8.7B | 7.79B | 18.34B | 21.98B | 11.65B |
International | 6.46B | 4.04B | 12.51B | 15.78B | 7.76B |
Managers: Pfizer Inc
Director | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 63 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
Lidia Fonseca
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Rady Johnson
CMP | Compliance Officer | 64 | 2013-11-30 |
Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
Members of the board: Pfizer Inc
Manager | Title | Age | Since |
---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 67 | 2007-08-31 |
Helen Hobbs
BRD | Director/Board Member | 72 | 2011-12-11 |
Shantanu Narayen
BRD | Director/Board Member | 61 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 63 | 2019-12-31 |
Jim Smith
BRD | Director/Board Member | 65 | 2014-06-25 |
Director/Board Member | 67 | 2015-06-24 | |
Ronald Blaylock
BRD | Director/Board Member | 65 | 2017-02-22 |
Dan Littman
BRD | Director/Board Member | 72 | 2018-03-04 |
Scott Gottlieb
BRD | Director/Board Member | 52 | 2019-06-26 |
James Quincey
BRD | Director/Board Member | 60 | 2020-02-26 |
Holdings: Pfizer Inc
Name | Equities | % | Valuation |
---|---|---|---|
HALEON PLC 7.31% | 661,709,764 | 7.31% | 3,080,808,171 $ |
PFIZER LIMITED 63.92% | 29,243,042 | 63.92% | 1,531,443,488 $ |
BIONTECH SE 1.54% | 3,658,361 | 1.54% | 452,795,341 $ |
ARVINAS, INC. 5.03% | 3,457,815 | 5.03% | 60,892,122 $ |
5,376,344 | 7.62% | 56,021,504 $ | |
ALLOGENE THERAPEUTICS, INC. 10.51% | 22,032,040 | 10.51% | 39,657,672 $ |
CSTONE PHARMACEUTICALS 9.03% | 115,928,803 | 9.03% | 34,820,375 $ |
AKERO THERAPEUTICS, INC. 0.75% | 562,626 | 0.75% | 30,426,814 $ |
VALNEVA 5.88% | 9,549,761 | 5.88% | 27,082,072 $ |
WAVE LIFE SCIENCES LTD. 1.23% | 1,875,000 | 1.23% | 21,693,750 $ |
Company details: Pfizer Inc

Group companies: Pfizer Inc
Name | Category and Sector |
---|---|
Pfizer Export Co.
![]() Pfizer Export Co. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Export Co. is an Irish company located in Cork. The firm develops and manufactures pharmaceutical products. |
Pharmaceuticals: Major
|
Pfizer Italia Srl
![]() Pfizer Italia Srl Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Italia Srl is a pharmaceutical company based in Latina, Italy. The Italian company manufactures pharmaceutical products. The company was founded in 1955. The CEO is Paivi Kerkola. |
Pharmaceuticals: Major
|
Viatris Netherlands BV
![]() Viatris Netherlands BV Medical DistributorsDistribution Services Part of Viatris, Inc., Viatris Netherlands BV is a Dutch company that wholesales pharmaceutical, cosmetics, and perfumes and functions as a financial holding company. The company is located in the Netherlands. |
Medical Distributors
|
Pfizer Overseas LLC | |
Pfizer Luxembourg SARL |
Medical Distributors
|
Other Pharmaceuticals
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-3.00% | -3.88% | +11.41% | +246.24% | 760B | ||
-0.70% | +1.98% | -1.12% | -6.67% | 376B | ||
-1.50% | -11.35% | -34.17% | +73.38% | 349B | ||
-0.30% | +1.19% | +9.22% | +33.23% | 340B | ||
-1.11% | +1.90% | +29.62% | -13.94% | 264B | ||
-2.14% | +0.93% | +20.40% | +39.70% | 229B | ||
-1.67% | -4.89% | -34.40% | +6.68% | 210B | ||
-2.46% | -1.51% | +8.62% | +20.43% | 210B | ||
-1.16% | -0.81% | +0.72% | +30.02% | 157B | ||
Average | -1.56% | -1.83% | +1.15% | +47.67% | 321.55B | |
Weighted average by Cap. | -1.73% | -2.25% | +2.30% | +82.03% |
- Stock Market
- Equities
- PFE Stock
- Stock
- Company Pfizer Inc